Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Egaten study: triclabendazole for fasciolosis
jRCTs071190020Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Aug 2019
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of triclabendazole in fascioliasis, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: efficacy rate. Started Aug 2019; status: recruiting.
02
Drugs
triclabendazole
03
Conditions
fascioliasis
Beyond the preview
Go deeper on jRCTs071190020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071190020.